Lymphogranuloma venereum

Sexually Transmitted Diseases: Epidemiology, Pathology, Diagnosis, and Treatment

Volumn , Issue , 2023, Pages 117-128

  Neves, René Garrido ^a   da Rosa Santos, Omar Lupi ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 20244368845     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780367811457-7     Document Type: Chapter

References (33)

1. Oehme A, Musholt PB, Dreesbach K. Chlamydiae as pathogen — an overview of diagnostic techniques, clinical features, and therapy of human infection. Klin. Wochenschr., 69: 463, 1991.
2. Hayes LJ, Yearsley P, Treharne JD, et al. Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum iso¬lates of Chlamydia trachomatis. Infect. Immun., 62: 5659, 1994.
3. Bauwens JE, Lampe MF, Suchland RJ, et al. Infection with Chlamydia trachomatis lymphogran¬uloma venereum serovar LI in homosexual men with proctitis: molecular analysis of an unusual case cluster. Clin. Infect. Dis., 20: 576, 1995.
4. de le Maza LM, Fielder TJ, Carlson EJ, et al. Sequence diversity of the 60-kilodalton protein and of a putative 15-kilodalton protein between the trachoma and lymphogranuloma ve¬nereum biovars of Chlamydia trachomatis. Infect. Immun., 59: 1196, 1991.
5. Watson MW, Lambden PR, Ward ME, et al. Chlamydia trachomatis 60 Kda cysteine rich outer membrane protein: sequence homology between trachoma and LGV biovars. FEMS Microbiol. Lett., 53: 293, 1989.
6. Chen JC, Stephens RS. Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol. Microbiol, 11: 501, 1994.
7. Igietseme JU, Magee DM, Williams DM, et al. Role for CD8+ cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect. Immun., 62: 5195,1994.
8. James SP, Graeff AS, Zeitz M, et al. Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates. Infect. Immun., 55: 1137, 1987.
9. Zeitz M, Quinn TC, Graeff AS, et al. Mucosal T cell provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in nonhuman primates. Gastroenterology, 94: 353, 1988.
10. King A, Nicol C, Rodin P Venereal Diseases, 4th ed., Bailliere Tindall, London, 1980, 231.
11. Bechelli LM, Curban GV. Comp. Dermatol, 6th ed., Atheneu S.A., Sao Paulo, 1988, 195.
12. Azulay RD. Doena de Nicolas-Favre-Durand. Clinica e experimentaqao. Rev. Flum. Med., 8: 7, 1943.
13. Eichmann A. Sexually transmissible diseases following travel in tropical countries. Schweiz. Med. Wochenschr., 123: 1250, 1993.
14. Sales JB. Doenga de Nicolas-Favre e sua incidencia entre meretrizes de Fortaleza. Rev. Bras. Med., 10: 269, 1953.
15. Panizza E, Nigro M, Pasquale R, et al. Epidemiologic considerations apropos of 6 cases of lymphogranuloma venereum recorded in Sicily in a 1-year period. G. Ital. Dermatol. Venereol, 122: 11, 1987.
16. Scieux C, Barnes R, Bianchi A, et al. Lymphogranuloma venereum: TJ cases in Paris. J. Infect. Dis., 160: 662, 1989.
17. Bogaerts J, Ricart CA, Van Dick E, et al. The etiology of genital ulceration in Rwanda. Sex. Trans. Dis., 16: 123, 1989.
18. Sischy A, L'Exposto F, Dangor Y, et al. Syphilis serology in patients with primary syphilis and non-treponemal sexually transmitted diseases in southern Africa. Genitourin. Med., 67: 129, 1991.
19. Elgart ML. Sexually transmitted diseases of the vulva. In: Vulvar Diseases, Turner MLC, Mariniff SC, Eds. W.B. Saunders, Philadelphia, 1992, 387.
20. Ghinsberg RC, Firsteter-Gilburd E, Mates A, et al. Rectal lymphogranuloma venereum in a bisexual patient. Microbiologica, 14: 161, 1991.
21. Watson DJ, Parker AJ, Macleod TI. Lymphogranuloma venereum of the tonsil. J. Laryngol. Otol, 104: 331, 1990.
22. Burgoyne RA. Lymphogranuloma venereum. Prim. Care, 17: 153, 1990.
23. Buus DR, Pflugfelder SC, Schachter J, et al. Lymphogranuloma venereum conjunctivitis with a marginal corneal perforation. Ophthalmology, 95: 799, 1988.
24. Jeanpretre M, Harms M, Saurat JH. Stenosing anal mass and veneral lymphogranuloma. Schweiz. Med. Wochenschr., 124: 1587, 1994.
25. O'Farrell N, Hoosen AA, Coetzee KD, et al. Genital ulcer disease: Accuracy of clinical diag-nosis and strategies to improve control in Durban, South Africa. Genitourin. Med., 70: 7,1994.
26. Paris-Hamelin A, Catalan F. Techniques de laboratoires applicables aux diagnostics des M.S.T. Librairie le Francois. Paris, 1978, Chap. 6.
27. Mittal A, Sachdeva KG. Monoclonal antibody for the diagnosis of lymphogranuloma ve-nereum: A preliminary report. Br. J. Biomed. Sci., 50: 3, 1993.
28. Schachter J. Chlamydial infection. N. Engl J. Med., 298: 428, 1978.
29. Tavares W. Manual de Antibidticos para o Estudante de Medicina, 3rd ed., Atheneu S.A., Rio de Janeiro, 1988.
30. Cunha BA, Garabedian SM. Tetracyclines in urology: current concepts. Urology, 36: 548,1990.
31. Agakishiev DD, Kuliev TG. The combined treatment with doxycycline and methyluracil of a patient with lymphogranuloma venereum. Vestn. Dermatol. Venereol., 1: 77, 1990.
32. Linnemann CC, Heaton CL, Ritchey M. Treatment of Chlamydia trachomatis infections: com-parison of 1 and 2 g doses of erythromycin for seven days. Sex. Trans. Dis., 14: 102, 1987.
33. Chopda NM, Desai DC, Sawant PD, et al. Rectal lymphogranuloma venereum in association with rectal adenocarcinoma. Ind. J. Gastroenterol, 13: 103, 1994.